Sopharma AD (WSE: SPH)
Poland
· Delayed Price · Currency is PLN 13.05
+0.05 (0.38%)
Nov 20, 2024, 1:28 PM CET
Sopharma AD Revenue
Sopharma AD had revenue of 494.18M BGN in the quarter ending June 30, 2024, with 9.13% growth. This brings the company's revenue in the last twelve months to 1.97B, up 10.48% year-over-year. In the year 2023, Sopharma AD had annual revenue of 1.89B with 12.95% growth.
Revenue (ttm)
1.97B BGN
Revenue Growth
+10.48%
P/S Ratio
n/a
Revenue / Employee
418.14K BGN
Employees
4,721
Market Cap
2.12B PLN
Revenue Chart
* This company reports financials in BGN.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.89B | 216.43M | 12.95% |
| Dec 31, 2022 | 1.67B | 60.17M | 3.73% |
| Dec 31, 2021 | 1.61B | 165.21M | 11.42% |
| Dec 31, 2020 | 1.45B | 158.02M | 12.27% |
| Dec 31, 2019 | 1.29B | 100.28M | 8.44% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Krka, d. d. | 8.14B |
| NEUCA S.A. | 12.34B |
| Synektik Spólka Akcyjna | 618.67M |
| Celon Pharma S.A. | 206.81M |
| Voxel S.A. | 476.19M |
| Ryvu Therapeutics S.A. | 91.18M |
| Selvita S.A. | 329.02M |
| Centrum Medyczne ENEL-MED S.A. | 680.32M |